· 14/02/2020Recruiting
Clinical trial OAKS-DERBY: efficacy and safety of APL-2 in the treatment of geographic atrophy secondary to AMD
· 26/11/2019Recruiting
TALON clinical trial: Efficacy and safety of brolacizumab in the treatment of exudative AMD
· 13/11/2019Recruiting
Research project MICROBEYEOME
· 09/04/2019
LUCERNE clinical trial: efficacy and safety of FARICIMAB regarding aflibercept in the treatment of exudative age-related macular degeneration
· 03/03/2019
RHINE – Phase III study in the treatment of diabetic macular oedema
· 03/10/2018
Clinical trial THR-317-002: Efficacy and safety of THR-317 with ranibizumab in the treatment of diabetic macular oedema
· 03/10/2018
Clinical Trial KESTREL: Efficacy and safety of brolucizumab in comparison with aflibercept in diabetic macular edema
· 10/05/2018
Clinical trial OPH2005: Efficacy and safety of Zimura in the treatment of Stargardt’s disease
· 31/03/2016
Proxima A: Epidemiological study of the progression of Geographic Atrophy secondary to Age-Related Macular Degeneration (GX29633)
· 31/03/2016
Proxima B: Epidemiological study of the progression of Geographic Atrophy secondary to Age-Related Macular Degeneration (GX29639)
· 21/09/2015
HARRIER: Clinical trial on patients with choroidal neovascularisation secondary to AMD
· 29/01/2015
CHROMA: Clinical Trial of Lampalizumab for Geographic Atrophy Secondary to Age-Related Macular Degeneration
· 19/12/2014
FOVISTA NR: Clinical Trial for neovascular age-related macular degeneration
· 21/12/2014
LITE: Development of Advanced Laser Imaging Techniques for the anterior and posterior Eye
· 01/01/2015
FOVISTA: Clinical Trial for subfoveal neovascular age-related macular degeneration